Trial Profile
Study of berberine and sorafenib on the growth of liver cancer cells
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Dec 2018
Price :
$35
*
At a glance
- Drugs Berberine (Primary) ; Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 03 Dec 2018 New trial record